Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Schizophrenia

  Free Subscription


14.09.2026

1 Acta Psychiatr Scand
2 Br J Psychiatry
3 Can J Psychiatry
1 Clin Neuropharmacol
1 J Clin Psychopharmacol
1 Med J Aust
2 Mol Psychiatry
2 Nat Genet
2 Psychiatry Res
3 Psychol Med
7 Schizophr Res


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Psychiatr Scand

  1. DAMIANI S, Orlandi M, Provenzani U, Bortolin E, et al
    Unraveling Suicidal Ideation and Behaviors in a Global Cohort of Individuals at Clinical High-Risk for Psychosis: Multivariable Correlates and Subthreshold Psychotic Symptoms.
    Acta Psychiatr Scand. 2026 Sep 11. doi: 10.1111/acps.70138.
    PubMed         Abstract available


    Br J Psychiatry

  2. FERNANDEZ-EGEA E, Krishnadas R
    The clozapine gap in early psychosis: a system problem, not a monitoring one: Commentary on Williams et al, from early intervention in psychosis to intensive care.
    Br J Psychiatry. 2026 Sep 10:1-2. doi: 10.1192/bjp.2026.10782.
    PubMed        

  3. FORMANEK T, Lynall ME, Osimo EF
    Immune dysregulation in depression and psychosis: summary of current evidence and future perspectives.
    Br J Psychiatry. 2026 Sep 8:1-3. doi: 10.1192/bjp.2026.10761.
    PubMed         Abstract available


    Can J Psychiatry

  4. YANG L, Ross K, Palmer M, Ye Q, et al
    Adherence and Acceptability of Smartphone- and Wearable-Based Digital Phenotyping in Patients With First-Episode Psychosis: Observance et acceptabilite du phenotypage numerique fonde sur les telephones intelligents et les objets personnels connectes c
    Can J Psychiatry. 2026 Sep 11:7067437261486958. doi: 10.1177/07067437261486958.
    PubMed         Abstract available

  5. MIRABELLI J, MacKillop J, Streiner D, Korostil M, et al
    Cannabis Use Interacts With Psychosis Vulnerability in Borderline Personality Disorder: La consommation de cannabis interagit avec la vulnerabilite a la psychose dans le trouble de la personnalite limite.
    Can J Psychiatry. 2026 Sep 11:7067437261486962. doi: 10.1177/07067437261486962.
    PubMed         Abstract available

  6. SKIBA RM, Woodward TS, Caramanna I, Honer WG, et al
    A Multivariate Approach to Communication Impoverishment and Cognitive Performance in Treatment-Resistant Schizophrenia: Analyse a plusieurs variables portant sur l'appauvrissement de la communication et la performance cognitive dans les cas de schizop
    Can J Psychiatry. 2026 Sep 7:7067437261484787. doi: 10.1177/07067437261484787.
    PubMed         Abstract available


    Clin Neuropharmacol

  7. DEUTSCH SI, Elikan J, Spiegel DR, Cockerham MC, et al
    Last of the Just: A Novel Highlighting Descriptive Relations Between Trauma-induced Episodes of Dissociation and Psychosis. Does Pathologic Disruption of NMDA Receptor-mediated Neurotransmission Underlie These Relations and Serve as a Promising Therap
    Clin Neuropharmacol. 2026 Jul 31. doi: 10.1097/WNF.0000000000000700.
    PubMed         Abstract available


    J Clin Psychopharmacol

  8. OZBAYIR CI, Gonul AS
    Management of Schizophrenia With Clozapine in the Context of Comorbid Waldenstrom's Macroglobulinemia.
    J Clin Psychopharmacol. 2026 Sep 9. doi: 10.1097/JCP.0000000000002256.
    PubMed        


    Med J Aust

  9. SUETANI S, Dark F, Every-Palmer S, Galletly C, et al
    A Summary for Non-Psychiatrists of the Australian and New Zealand Journal of Psychiatry Grading of Recommendations, Assessment, Development and Evaluations (GRADE) Guidelines for the Management of Schizophrenia.
    Med J Aust. 2026;224:e70287.
    PubMed         Abstract available


    Mol Psychiatry

  10. XIONG Y, Wu G, Tang X, Yang Y, et al
    Dynamic, differentiated clinical trajectories and prediction in clinical high risk for psychosis.
    Mol Psychiatry. 2026 Sep 8. doi: 10.1038/s41380-026-03870.
    PubMed         Abstract available

  11. BACH SV, Punzi G, Smith NE, Mukherjee S, et al
    BDNF-DT and BDNF-AS-DT: novel genes in the BDNF locus.
    Mol Psychiatry. 2026;31:6069-6081.
    PubMed         Abstract available


    Nat Genet

  12. PEYROT WJ, Panagiotaropoulou G, Olde Loohuis LM, Adams MJ, et al
    Distinguishing different psychiatric disorders using DDx-PRS.
    Nat Genet. 2026;58:2371-2380.
    PubMed         Abstract available

  13. CHEN Y, Feng Q, Lam M, Yu M, et al
    Contribution of copy number variants to schizophrenia in East Asian populations.
    Nat Genet. 2026 Sep 11. doi: 10.1038/s41588-026-02732.
    PubMed         Abstract available


    Psychiatry Res

  14. SILVERMAN IH, Kaur D, Campbell LM, Mahmood Z, et al
    Demographic moderators of the relationship between psychiatric diagnosis and functional capacity in people with serious mental illness.
    Psychiatry Res. 2026;365:117386.
    PubMed         Abstract available

  15. BURKHARDT E, Lerch S, Fluckiger R, Cavelti M, et al
    Clinical and psychosocial factors related to change and therapy attendance during cognitive-behavioral therapy for young people at ultra high-risk of psychosis.
    Psychiatry Res. 2026;366:117423.
    PubMed         Abstract available


    Psychol Med

  16. GONZALEZ CHONG R, Obiajulu D, Thibeau H, Safa S, et al
    Stakeholder perspectives on artificial intelligence in schizophrenia care.
    Psychol Med. 2026;56:e265.
    PubMed         Abstract available

  17. MILLER-SILVA C, Illingworth BJG, Martey K, Mujirishvili T, et al
    No evidence for a generalised predictive processing deficit in psychosis: A meta-analysis.
    Psychol Med. 2026;56:e268.
    PubMed         Abstract available

  18. ASHLEY SA, Merritt K, Solmi F, Luque Laguna P, et al
    Course of head growth from birth to adolescence across the psychosis spectrum.
    Psychol Med. 2026;56:e267.
    PubMed         Abstract available


    Schizophr Res

  19. PERFALK E, Damgaard JG, Danielsen AA, Ostergaard SD, et al
    Predicting clozapine initiation among patients with schizophrenia via machine learning trained on electronic health record data.
    Schizophr Res. 2026;297:461-471.
    PubMed         Abstract available

  20. VAN DER VELDE DM, de Haan L, Batalla A, Sommer IE, et al
    Polysubstance use after remission in first-episode psychosis: Associations with positive symptoms and self-care.
    Schizophr Res. 2026;297:454-460.
    PubMed         Abstract available

  21. MORITZ S, Flachsenberg ME, Meinhart A, Ishikawa R, et al
    Should schizophrenia be renamed? Patients' preferences and what anti-stigma campaigns may learn from the history of the term "Black" in the United States.
    Schizophr Res. 2026;297:438-444.
    PubMed         Abstract available

  22. JIN JW, Winkler CJ, Blunt HB, Riblet NB, et al
    Effect of dopamine partial agonist antipsychotics on suicide risk in persons with schizophrenia and schizoaffective disorders: A systematic review and meta-analysis.
    Schizophr Res. 2026;297:430-437.
    PubMed         Abstract available

  23. WANG X, Tang Q, Xu H, Keshavan MS, et al
    Characteristics of treatment-naive individuals with chronic schizophrenia and the reported reasons for non-treatment: A two-year follow-up study in Northwest China.
    Schizophr Res. 2026;297:420-429.
    PubMed         Abstract available

  24. CHEN J, Zhang F, Zhang R, Ji M, et al
    Glymphatic system alterations in schizophrenia evaluated by the DTI-ALPS index: A systematic review and meta-analysis.
    Schizophr Res. 2026;297:403-412.
    PubMed         Abstract available

  25. KRONENBUERGER M, Yoshida K, Li PY, Tavakoli E, et al
    Pharmacogenomics of antipsychotic-induced weight gain: A systematic review.
    Schizophr Res. 2026;296:175-198.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum